BillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete, the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy test, Northstar, that combines treatment selection with monitoring. To date, over 500,000 patients have benefited from our innovative and precise diagnostic tests, and our Annual Recurring Revenue (ARR) has grown from $0 to $125 million in the last ~4 years.
BillionToOne has successfully raised close to $400 million in funding, with a notable $130 million Series D round completed in June 2024, resulting in a company valuation of over $1 billion. This funding has come from prestigious global institutional investors, including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. BillionToOne has recently been recognized by Forbes as one of America's Best Startup Employers for 2024, highlighting the company's exceptional work environment and commitment to innovation.
Our team has grown significantly and we now proudly employ over 400 highly skilled individuals. Despite substantial growth, we have successfully maintained the unique culture that has defined BillionToOne from inception, continuing to cultivate a team that is not only diverse and passionate but also innovative. Headquartered in Menlo Park, California, with an additional facility in Union City, California, BillionToOne remains at the forefront of significant advances in molecular diagnostics, evidenced by the recent announcement of clinical outcomes data for its Unity Fetal Risk Screen and new advancements in cancer diagnostics.
We are looking for a driven Pre-Analytical Supervisor to supervise the pre-analytical phase of testing for Northstar, BillionToOne's Oncology product. This role involves supervising a team of Clinical Laboratory Associates performing specimen receipt, accessioning, sample preparation and processing, ensuring all processes adhere to the highest standards of quality and compliance. The Pre-Analytical Supervisor will play a crucial role in maintaining the efficiency and accuracy of our laboratory operations, contributing directly to the quality of our diagnostic products. This role is a full-time onsite position in Menlo Park, CA.
Shift Hours: Monday - Friday, 8:00 AM - 4:30 PM (occasional Saturdays)
Responsibilities: Supervise the pre-analytical phase of testing, including specimen receipt, accessioning, and sample preparation and processingEnsure all pre-analytical processes comply with CLIA/CAP regulationsTrain, mentor, and manage a team of pre-analytical staff, fostering a culture of quality and complianceMonitor workflow and ensure timely processing of specimens to meet TATDevelop, implement, and maintain standard operating procedures (SOPs) for pre-analytical activitiesActing as a liaison between specimen handling, customer services, and various laboratory departments, the supervisor coordinates specimen receipt and analytical and post-analytical phases with seamless communication and collaborationPerform quality assurance procedures and maintain accurate records of pre-analytical activitiesTroubleshoot and resolve issues related to specimen handling and processingPrepare and review controlled documents, including equipment maintenance logs and personnel recordsRequirements: Bachelor's degree in biology, molecular biology, or a related fieldMinimum of 2 years of experience in a clinical laboratory, with at least 1 year in a supervisory role. (molecular and/or high-complexity laboratory experience preferred)Strong understanding of molecular biology techniques, particularly in the context of NGSSelf-starter and dynamic team playerEffective written and verbal communication skillsAbility to multitask and work independently in a fast-paced environmentStrong attention to detail and ability to work flexibly and well under given timeframesFamiliarity with laboratory information management systems (LIMS), quality management systems (QMS), Google applications, and Microsoft OfficeNice-To-Haves: Experience in a start-up environmentAdvanced knowledge of DNA purification, PCR, electrophoresis, or next-generation sequencingPrevious experience in a high-complexity clinical laboratory setting.At BillionToOne, we are proud to offer a combination of a (1) base pay range (actual amount offered is based on experience and salary/equity options split that the candidate chooses) (2) generous equity options offering, on top of (3) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave etc.).
For this position, the base pay range is: $90,000-$110,000 per year.
BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
#J-18808-Ljbffr
